0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

PROCAINE INTRAVENOUSLY IN TREATMENT OF DELAYED SERUM SICKNESS

DAVID STATE, M.D.; OWEN H. WANGENSTEEN, M.D.
JAMA. 1946;130(15):990-995. doi:10.1001/jama.1946.02870150008002.
Text Size: A A A
Published online

In the course of exploring the possibility of employing crystallized bovine albumin (Cohn) as a blood substitute, instances of delayed serum sickness characterized by myalgia, arthralgia, urticaria, petechial rash and fever occurring ten to twenty-one days after injection was noted in approximately 8 per cent of the patients injected. The usual therapeutic agents such as epinephrine, ephedrine, codeine and calcium gluconate, although helpful in the mild cases, afforded no relief in the more severe reactions. The generalized myalgia and arthralgia in some cases were especially severe, and it was primarily to relieve distressing pain that intravenous procaine was given. However, the subsidence of all the manifestations of serum sickness was a pleasant surprise and occurred with such frequency as to encourage its employment in all subsequent instances of serum sickness.

Furthermore, we have attempted to explore its utility in the management of other states of hypersensitivity. A series of preliminary

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();